AMY NUTTING: Open Payments
NPI 1013992080 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 30 payments from 12 companies in 2025. Trend: 2023 $481 · 2024 $956 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $249 |
| Organon LLC | 4 | $158 |
| GENZYME CORPORATION | 3 | $99 |
| ABBVIE INC. | 5 | $85 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $76 |
| Almirall LLC | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| LEO Pharma Inc. | 1 | $31 |
| PFIZER INC. | 2 | $31 |
| Galderma Laboratories, L.P. | 1 | $27 |
Products named: TREMFYA, VTAMA, DUPIXENT, SKYRIZI, ILUMYA, Seysara, Rhapsido, ANZUPGO.
Industry payments across OH — which companies pay providers there.
